Blood News and Research

RSS

Vaping beats traditional tools for quitting smoking

The review indicates nicotine e-cigarettes could surpass traditional quit aids in effectiveness, but lingering safety uncertainties warrant further research.

31 Mar 2026

Uncovering the hidden retinal risks of modern dentistry

Dentists are exposed to intense lighting for long hours, but its long-term impact on eye health is often overlooked. This study evaluates whether chronic exposure to dental lighting, especially blue and white LEDs, can damage the retina and disrupt its normal function. By combining human data with advanced imaging and animal models, the research uncovers hidden occupational risks and highlights the need for safer lighting practices to help protect dentists' vision.

31 Mar 2026

Largest bipolar disorder dataset launched to advance personalized care

BD²: Breakthrough Discoveries for thriving with Bipolar Disorder today announced the first public release of data from the BD² Integrated Network Longitudinal Cohort Study (LCS).

30 Mar 2026

Collaboration advances EMA601 as potential first-in-class stroke therapy

Boehringer Ingelheim and the Lower Franconian biotech company EMFRET Analytics have signed a cooperation and license agreement for the preclinical development program of the GPVI‑blocking antibody EMA601.

30 Mar 2026

Dual imaging reveals hidden causes of heart attacks without blockages

When Ashley Perlow felt a sharp pain shoot across her chest and into both wrists, she didn't think it could be a heart attack. She was 36, a new mom, and otherwise healthy.

30 Mar 2026

New initiative aims to improve care for people living with Fontan circulation

The lifesaving surgery used to treat children with single ventricle heart disease, the Fontan procedure, can pose serious health complications throughout life.

30 Mar 2026

Artemin identified as marker and target in feline osteoarthritis

By comparing osteoarthritis pain pathways known to be active in dogs and humans to those in cats with degenerative joint disease (DJD), researchers found that elevation of a particular molecule, artemin, could serve as a marker of disease (and possibly pain) as well as a potential therapeutic target.

30 Mar 2026

Study reveals CAR T approach for hard-to-treat solid tumors

Chimeric antigen receptor T-cell therapy - CAR T for short - has been a major advance in treating blood cancers like leukemia and lymphoma.

30 Mar 2026

Measuring heart fat with AI improves cardiovascular risk prediction

Mayo Clinic research identified a powerful new way to improve the prediction of a patient's long-term cardiovascular disease risk by enhancing a routinely performed imaging test with artificial intelligence (AI).

30 Mar 2026

Community health fair promotes cancer awareness and preventive screenings

Ochsner Health welcomed Iberville Parish residents and families on Saturday, March 28 for the Iberville Parish Health Fair & Community Celebration, a no-cost community event focused on cancer awareness and prevention, and access to care close to home.

30 Mar 2026

Breathing in common disinfectant chemicals may be more harmful than oral ingestion

Breathing in common disinfectant chemicals known as quaternary ammonium compounds, or QACs, may be far more harmful than swallowing them, according to a mouse study led by researchers at the University of California, Davis.

30 Mar 2026

Time-restricted eating improves hormone levels in women with PCOS

Polycystic ovary syndrome, or PCOS, affects as many as 18% of all childbearing-age women. The condition occurs when a woman's body produces too much of a group of hormones called androgens, chiefly testosterone. Menstrual irregularity, obesity and even infertility can result.

30 Mar 2026

AI eye exams accurately identify heart disease risk during routine visits

A new system that uses artificial intelligence (AI) to assess cardiovascular risk based on images of the eye captured during eye exams demonstrated strong correlation with a standard cardiovascular risk assessment, according to a study presented at the American College of Cardiology's Annual Scientific Session (ACC.26).

30 Mar 2026

Triglyceride-lowering drug olezarsen fails to reduce arterial plaque

Despite experiencing significant reductions in triglycerides, patients with triglycerides over 150 mg/dL and a high risk of atherosclerosis did not experience any significant change in the amount of non-calcified plaque in their coronary arteries after taking the triglyceride-lowering drug olezarsen, in a one-year sub-study presented at the American College of Cardiology's Annual Scientific Session.

30 Mar 2026

Culturally tailored food programs significantly lower blood pressure in minority adults

Black and Hispanic adults with high blood pressure (hypertension) who received a culturally tailored food-based intervention with dietitian coaching experienced a significant drop in blood pressure compared with those who received an equivalent amount of fresh produce without additional supports, according to a study presented at the American College of Cardiology's Annual Scientific Session (ACC.26).

30 Mar 2026

Red blood cell exchange transfusion may provide benefits for patients with severe babesiosis

A new study led by investigators from Mass General Brigham and Yale School of Public Health reveals that red blood cell exchange transfusion (ET) may provide critical benefits for patients hospitalized with severe babesiosis.

30 Mar 2026

Discontinuing beta-blockers after heart attack found to be safe for low-risk patients

Among stable, relatively low-risk patients who had previously suffered a heart attack, discontinuing beta-blockers after at least one year was found to be non-inferior, or comparable, to continuing beta-blockers in terms of death, another heart attack or hospitalization for heart failure, according to a study presented at the American College of Cardiology's Annual Scientific Session.

30 Mar 2026